323 related articles for article (PubMed ID: 17213254)
41. Assessment of health-related quality of life in individuals with depressive symptoms: validity and responsiveness of the EQ-5D-3L and the SF-6D.
Stolz M; Albus C; Beutel ME; Deter HC; Fritzsche K; Herrmann-Lingen C; Michal M; Petrowski K; Ronel J; Schultz JH; Söllner W; Weber C; de Zwaan M; Krauth C
Eur J Health Econ; 2023 Nov; 24(8):1297-1307. PubMed ID: 36385438
[TBL] [Abstract][Full Text] [Related]
42. Evaluating the psychometric properties of the EQ-5D-5L and SF-6D among patients with haemophilia.
Xu RH; Dong D; Luo N; Wong EL; Wu Y; Yu S; Yang R; Liu J; Yuan H; Zhang S
Eur J Health Econ; 2021 Jun; 22(4):547-557. PubMed ID: 33761029
[TBL] [Abstract][Full Text] [Related]
43. Validity of utility measures for women with urge, stress, and mixed urinary incontinence.
Harvie HS; Shea JA; Andy UU; Propert K; Schwartz JS; Arya LA
Am J Obstet Gynecol; 2014 Jan; 210(1):85.e1-6. PubMed ID: 24055585
[TBL] [Abstract][Full Text] [Related]
44. Comparison between different health state utility instruments in patients with fibromyalgia.
Franco KFM; Cabral CMN; Salvador EMES; Miyamoto GC
Braz J Phys Ther; 2021; 25(5):573-582. PubMed ID: 33766462
[TBL] [Abstract][Full Text] [Related]
45. Extension from inpatients to outpatients: validity and reliability of the Oxford Knee Score in measuring health outcomes in patients with knee osteoarthritis.
Xie F; Ye H; Zhang Y; Liu X; Lei T; Li SC
Int J Rheum Dis; 2011 May; 14(2):206-10. PubMed ID: 21518321
[TBL] [Abstract][Full Text] [Related]
46. Health-related quality of life and utility: comparison of ankylosing spondylitis, rheumatoid arthritis, and systemic lupus erythematosus patients in Taiwan.
Chen HH; Chen DY; Chen YM; Lai KL
Clin Rheumatol; 2017 Jan; 36(1):133-142. PubMed ID: 27837342
[TBL] [Abstract][Full Text] [Related]
47. Mapping the cancer-specific EORTC QLQ-C30 to the preference-based EQ-5D, SF-6D, and 15D instruments.
Kontodimopoulos N; Aletras VH; Paliouras D; Niakas D
Value Health; 2009; 12(8):1151-7. PubMed ID: 19558372
[TBL] [Abstract][Full Text] [Related]
48. Estimating the burden of disease in chronic pain with and without neuropathic characteristics: does the choice between the EQ-5D and SF-6D matter?
Torrance N; Lawson KD; Afolabi E; Bennett MI; Serpell MG; Dunn KM; Smith BH
Pain; 2014 Oct; 155(10):1996-2004. PubMed ID: 25020004
[TBL] [Abstract][Full Text] [Related]
49. A review of the psychometric properties of generic utility measures in multiple sclerosis.
Kuspinar A; Mayo NE
Pharmacoeconomics; 2014 Aug; 32(8):759-73. PubMed ID: 24846760
[TBL] [Abstract][Full Text] [Related]
50. A comparison of generic, indirect utility measures (the HUI2, HUI3, SF-6D, and the EQ-5D) and disease-specific instruments (the RAQoL and the HAQ) in rheumatoid arthritis.
Marra CA; Woolcott JC; Kopec JA; Shojania K; Offer R; Brazier JE; Esdaile JM; Anis AH
Soc Sci Med; 2005 Apr; 60(7):1571-82. PubMed ID: 15652688
[TBL] [Abstract][Full Text] [Related]
51. Exploring the validity of estimating EQ-5D and SF-6D utility values from the health assessment questionnaire in patients with inflammatory arthritis.
Harrison MJ; Lunt M; Verstappen SM; Watson KD; Bansback NJ; Symmons DP
Health Qual Life Outcomes; 2010 Feb; 8():21. PubMed ID: 20149253
[TBL] [Abstract][Full Text] [Related]
52. A comparison between the EQ-5D and the SF-6D in patients with chronic obstructive pulmonary disease (COPD).
Chen J; Wong CK; McGhee SM; Pang PK; Yu WC
PLoS One; 2014; 9(11):e112389. PubMed ID: 25379673
[TBL] [Abstract][Full Text] [Related]
53. The relationship between body mass index and health-related quality of life: comparing the EQ-5D, EuroQol VAS and SF-6D.
Sach TH; Barton GR; Doherty M; Muir KR; Jenkinson C; Avery AJ
Int J Obes (Lond); 2007 Jan; 31(1):189-96. PubMed ID: 16682976
[TBL] [Abstract][Full Text] [Related]
54. Are condition-specific utilities more valid than generic preference-based ones in asthma? Evidence from a study comparing EQ-5D-3L and SF-6D with AQL-5D.
Kontodimopoulos N; Stamatopoulou E; Brinia A; Talias MA; Ferreira LN
Expert Rev Pharmacoecon Outcomes Res; 2018 Dec; 18(6):667-675. PubMed ID: 30048194
[TBL] [Abstract][Full Text] [Related]
55. Comparison of contemporaneous EQ-5D and SF-6D responses using scoring algorithms derived from similar valuation exercises.
Whitehurst DG; Norman R; Brazier JE; Viney R
Value Health; 2014 Jul; 17(5):570-7. PubMed ID: 25128050
[TBL] [Abstract][Full Text] [Related]
56. A head-to-head comparison of EQ-5D-5 L and SF-6D in Chinese patients with low back pain.
Ye Z; Sun L; Wang Q
Health Qual Life Outcomes; 2019 Apr; 17(1):57. PubMed ID: 30971265
[TBL] [Abstract][Full Text] [Related]
57. Quality-adjusted life expectancies in patients with rheumatoid arthritis--comparison of index scores from EQ-5D, 15D, and SF-6D.
Sørensen J; Linde L; Ostergaard M; Hetland ML
Value Health; 2012; 15(2):334-9. PubMed ID: 22433765
[TBL] [Abstract][Full Text] [Related]
58. Quality of Life and General Health After Elective Surgery for Cervical Spine Pathologies: Determining a Valid and Responsive Metric of Health State Utility.
Chotai S; Parker SL; Sivaganesan A; Godil SS; McGirt MJ; Devin CJ
Neurosurgery; 2015 Oct; 77(4):553-60; discussion 560. PubMed ID: 26191977
[TBL] [Abstract][Full Text] [Related]
59. The impact of differences in EQ-5D and SF-6D utility scores on the acceptability of cost-utility ratios: results across five trial-based cost-utility studies.
Joore M; Brunenberg D; Nelemans P; Wouters E; Kuijpers P; Honig A; Willems D; de Leeuw P; Severens J; Boonen A
Value Health; 2010; 13(2):222-9. PubMed ID: 19878492
[TBL] [Abstract][Full Text] [Related]
60. Comparison of health-related quality of life and functional recovery measurement tools in out-of-hospital cardiac arrest survivors.
Andrew E; Nehme Z; Bernard S; Smith K
Resuscitation; 2016 Oct; 107():57-64. PubMed ID: 27521474
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
